The private placement deal directly impacts DIH Holding US by providing it with $1.5 million in financing, which could be used for operational expenses, growth initiatives, or debt reduction. This influx of capital is likely to be viewed positively by investors, as it not only demonstrates confidence from an existing shareholder, OrbiMed, but also strengthens the company's financial position without immediately diluting the stock value due to the structured nature of the deal.